Trial Profile
Switching to duloxetine from other antidepressants: a regional multicentre trial comparing two switching techniques
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly and Company
- 14 Nov 2011 The extension phase of this trial is still ongoing in Spain, according to the European Clinical Trials Database.
- 13 Nov 2005 New trial record.